Jung Jihee, Kang Taeuk, Hwang Yoohyun, Ryoo Sungweon
Clinical Research Center, Masan National Tuberculosis Hospital, Changwon, South Korea.
Int J Mycobacteriol. 2022 Jan-Mar;11(1):23-29. doi: 10.4103/ijmy.ijmy_8_22.
Tuberculosis (TB) remains a serious public health burden in Korea. Mycobacterial Interspersed Repetitive Unit-Variable Number Tandem Repeat (MIRU-VNTR) is preferred for epidemiological TB investigation. Until recently, the difficulty lies in epidemiological TB investigation due to the absence of commercialized MIRU-VNTR in Korea. Here, we have evaluated the newly designed MIRU-VNTR kit by Kogenebiotech, Korea.
A total of 200 samples, where 100 are Mycobacrerium tuberculosis (M. tuberculosis), and the other 100 are non-M. tuberculosis, were used. Initially, the Kogenebiotech MIRU-VNTR typing kit (KoMIRU) was compared with Multilocus Variable Number Tandem Repeat Genotyping of M. tuberculosis typing kit (MVNTR) by Philip Supply for validation purpose. Then, Limit of Detection for DNA copies was optimized. Finally, KoMIRU and Genoscreen MIRU-VNTR typing kit (GeMIRU) were tested and comparatively analyzed for its specificity and sensitivity.
The study showed that the KoMIRU has slightly higher discriminatory power over MVNTR, 100% versus 97.5%. In comparative analysis, the KoMIRU has shown comparable capability as GeMIRU, showing 100% for sensitivity and specificity with a 95% CI value of 96.38 to 100.00%. Also, no discrepancies were observed on discriminated lineage strains between KoMIRU and GeMIRU. Out of 100, 84 were identified as Beijing strains, and remains were identified as NEW-1 (n = 8), Uganda (n = 6), East African Indian (EAI) (n = 6), Turkey (n = 2), and Haarlem (n = 1).
In this study, KoMIRU has shown a comparable capability to GeMIRU. Furthermore, previous researches had suggested an association between lineage strains and drug resistance; hence, the implementation of KoMIRU can help in TB control and prevention.
在韩国,结核病仍然是一项严重的公共卫生负担。分枝杆菌散布重复单位可变数目串联重复序列(MIRU-VNTR)在结核病流行病学调查中更受青睐。直到最近,由于韩国没有商业化的MIRU-VNTR,结核病流行病学调查仍存在困难。在此,我们对韩国Kogenebiotech公司新设计的MIRU-VNTR试剂盒进行了评估。
共使用了200份样本,其中100份为结核分枝杆菌,另外100份为非结核分枝杆菌。最初,为了进行验证,将Kogenebiotech公司的MIRU-VNTR分型试剂盒(KoMIRU)与Philip Supply公司的结核分枝杆菌多位点可变数目串联重复序列基因分型试剂盒(MVNTR)进行了比较。然后,对DNA拷贝的检测限进行了优化。最后,对KoMIRU和Genoscreen公司的MIRU-VNTR分型试剂盒(GeMIRU)进行了测试,并对其特异性和敏感性进行了比较分析。
研究表明,KoMIRU的鉴别能力略高于MVNTR,分别为100%和97.5%。在比较分析中,KoMIRU表现出与GeMIRU相当的能力,敏感性和特异性均为100%,95%置信区间值为96.38至100.00%。此外,在KoMIRU和GeMIRU之间的鉴别谱系菌株上未观察到差异。在100份样本中,84份被鉴定为北京菌株,其余分别被鉴定为NEW-1(n = 8)、乌干达(n = 6)、东非印度(EAI)(n = 6)、土耳其(n = 2)和哈勒姆(n = 1)。
在本研究中,KoMIRU表现出与GeMIRU相当的能力。此外,先前的研究表明谱系菌株与耐药性之间存在关联;因此,KoMIRU的应用有助于结核病的控制和预防。